Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerivastatin versus placebo for carotid atherosclerosis progression in type 2 diabetes
NL-OMON20255Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cerivastatin and simvastatin in type 2 diabetes mellitus (T2DM) and atherosclerosis (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Change in carotid intima-media thickness and distensibility. Started Aug 1999; status: active, not recruiting.
02
Drugs
cerivastatinsimvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)atherosclerosis
Beyond the preview
Go deeper on NL-OMON20255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20255.